Search
Searching Content by T. Reed Stephens from McDermott Will & Emery ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
First Of Its Kind: Drug Wholesaler Accepts DPA And Two Executives Face Criminal Charges In SDNY For Illegal Distribution Of Opioids
On April 23, 2019, the US Department of Justice (DOJ) announced it has entered into a deferred prosecution agreement with Rochester Drug Co-Operative, Inc. (RDC),
United States
22 May 2019
2
Health Care Enforcement Quarterly Roundup | Q4 2018
This latest installment of the Health Care Enforcement Quarterly Roundup reflects on trends that persisted in 2018 and those emerging trends that will carry us into 2019 and beyond.
United States
8 Feb 2019
3
Health Care Enforcement Quarterly Roundup | Q3 | September 2018
In the latest installment of Health Care Enforcement Quarterly Roundup, we examine key enforcement trends in the health care industry that we have observed over the past few months. In this issue,
United States
9 Oct 2018
4
Health Care Enforcement Quarterly Roundup Q3 | September 2018
In the latest installment of Health Care Enforcement Quarterly Roundup, we examine key enforcement trends in the health care industry that we have observed over the past few months.
United States
9 Oct 2018
5
Health Care Enforcement Quarterly Roundup (October 2018)
In the latest installment of Health Care Enforcement Quarterly Roundup, we examine key enforcement trends in the health care industry ...
United States
9 Oct 2018
6
Health Care Enforcement Quarterly Roundup - July 2018
Over the past 18 months, we have closely monitored the Trump administration's approach to health care enforcement issues, with a particular focus on whether prosecution of the False Claims Act (FCA) ...
United States
25 Apr 2018
7
DOJ Continues Action Against Medicare Advantage Plans, Showing Increased Focus On Intersection Of The FCA And Managed Care
Last year, DOJ intervened in United States ex rel. Poehling v. UnitedHealth Group., Inc. (C.D. Cal.). In this case, DOJ alleged FCA violations relating to Medicare Advantage ....
United States
23 Apr 2018
8
Private Equity Sponsor Named As FCA Defendant
DOJ also made news in February 2018 when it named a private equity firm as a co-defendant in United States ex rel. Medrano and Lopez v. Diabetic Care Rx, LLC d/b/a Patient Care America, e ...
United States
23 Apr 2018
9
DOJ Maintains Focus On FCA Enforcement Against Individuals
In September 2015, DOJ issued the well-known "Yates Memo" (named for then-Deputy Attorney General Sally Yates), which focuses on individual accountability for corporate wrongdoing.
United States
23 Apr 2018
10
Courts Continue To Interpret Escobar Favorably For FCA Defendants
One of the most significant developments in FCA litigation in recent years was the Supreme Court's unanimous 2016 ruling in Universal Health Services, Inc. v. United States ex rel. Escobar ...
United States
23 Apr 2018
11
DOJ Leadership Reaffirms Expanded Enforcement Of The FCA To Combat Opioid Epidemic
In his March 2018 confirmation hearing, President Trump's nominee to head DOJ's Civil Division, Joseph "Jody" Hunt, signaled that DOJ would continue with its aggressive enforcement of the FCA.
United States
23 Apr 2018
12
Guidance Memoranda Continue To Be Used By DOJ Leadership To Endorse Enforcement Priorities And Protocols
DOJ has long used guidance memoranda to reflect enforcement priorities and provide specific guidance to its prosecutors. This remains true in the Trump administration. In the first quarter of 2018 ...
United States
23 Apr 2018
13
DOJ Issues Memorandum Outlining Factors For Evaluating Dismissal Of Qui Tam FCA Cases In Which The Government Has Declined To Intervene
As first reported in the National Law Journal, the US Department of Justice (DOJ), Civil Division, recently issued an important memorandum to its lawyers handling qui tam cases filed under...
United States
30 Jan 2018
14
DOJ Announces Significant Shift Towards Affirmative Dismissal Of "Frivolous" Qui Tam Complaints: A New Exit Strategy For Defendants?
Attendees at the Health Care Compliance Association's Health Care Enforcement Compliance Institute are reporting that, Michael Granston, Director, Civil Frauds, Commercial Litigation Branch...
United States
17 Nov 2017
15
A Hospital's Deserving Stark And AKS Victory—But At What Cost?
Bingham is a serial relator who practices as a certified real estate appraiser in Tennessee and was unaffiliated with BayCare.
United States
12 Jun 2017
16
A Closer Look At Rigsby And The Supreme Court's Rejection Of Mandatory Dismissal For Seal Violations
In light of the rising civil monetary penalties under the FCA and the looming threat of bank-breaking treble damages, avenues to dismissal are paramount to defendants operating in industries...
United States
20 Dec 2016
17
DOJ's "Yates Memorandum" Calls For Increased Focus On Individuals In Investigating Allegations Of Both Criminal And Civil Corporate Wrongdoing
On September 9, 2015, the U.S. Department of Justice released a memorandum to prosecutors nationwide regarding "Individual Accountability for Corporate Wrongdoing," authored by Deputy Attorney General Sally Q. Yates.
United States
28 Sep 2015
18
Huge Stark Law Hospital Settlements And Physician Culpability - The New Normal Post-Tuomey?
After the federal government's victory against Tuomey Hospital, we have seen an increasing number of large False Claims Act (FCA) settlements with hospitals involving Stark Law allegations.
United States
28 Sep 2015
19
Can Satisfying A Regulatory Requirement Now Equate To Providing Illegal Remuneration?
The disposal of weak cases by the government through the intervention decision making process has always been a critical safety valve for non-culpable defendants.
United States
15 Sep 2015
20
Amarin Ruling Solidifies Off-Label Marketing Options But Raises Questions About False Claims Act Enforcement Action
While the Amarin decision is welcome news for the industry, drug manufacturers must still take care to analyze promotional statements to ensure that the content can be successfully defended as "truthful" and "non-misleading" speech.
United States
20 Aug 2015
Links to Result pages
 
1 2  
>>Next